| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.8M | +1.8% |
| Cost of Revenue | $5.9M | +135.2% |
| R&D Expense | $109.6M | -13.8% |
| SG&A Expense | $41.9M | -13.5% |
| Operating Income | -$130.7M | +21.3% |
| Interest Expense | $50.2M | +8.4% |
| Pre-tax Income | -$156.1M | +20.1% |
| Income Tax | $166K | -99.6% |
| Net Income | -$157.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $250.9M | -10.0% |
| Accounts Receivable | $20.3M | -19.3% |
| Inventory | $18.4M | +13.7% |
| Current Assets | $307.4M | -8.6% |
| Total Assets | $322.0M | -9.2% |
| Current Liabilities | $80.5M | +18.9% |
| Total Liabilities | $524.6M | +4.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$123.8M | -4.3% |
| Capital Expenditures | $867K | -73.0% |
| Investing Cash Flow | -$867K | +73.0% |
| Financing Cash Flow | $97.1M | +31.4% |
| Free Cash Flow | -$124.7M | -2.3% |
| +34.2% |
| EPS (Basic) | -$1.62 | +44.9% |
| EPS (Diluted) | -$1.62 | +44.9% |
| Stockholders' Equity |
| -$202.6M |
| -36.7% |